Monographs: Dosage forms: Specific monographs: Chloroquine sulfate tablets (Chloroquini sulfatis compressi)

Category. Antiamoebic drug; antimalarial drug.

Additional information. Strengths in the current WHO model list of essential medicines: 100 mg, 150 mg of chloroquine base. Strengths in the current WHO model list of essential medicines for children: 100 mg, 150 mg of chloroquine base.

200 mg of chloroquine sulfate (H2O) is approximately equivalent to 150 mg (146.7 mg) of chloroquine base.

Requirements

Comply with the monograph for Tablets.

Definition. Chloroquine sulfate tablets contain Chloroquine sulfate. They contain not less than 93.0% and not more than 107.0% of the amount of chloroquine sulfate (C18H26ClN3,H2SO4,H2O) stated on the label.

Identity tests

A. See the test described below under "Related substances". The principal spot obtained with solution A corresponds in position, appearance and intensity with that obtained with solution D.

B. Shake a quantity of the powdered tablets equivalent to 0.1 g of Chloroquine sulfate with 10 mL of water R and 1 mL of hydrochloric acid (~70 g/L) TS and filter. To the filtrate add 1 mL of barium chloride (50 g/L) TS; a white precipitate is produced.

Related substances

Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R2 as the coating substance and a mixture of 5 volumes of chloroform R, 4 volumes of cyclohexane R and 1 volume of diethylamine R as the mobile phase. Apply separately to the plate 2 μL of each of the following four solutions. For solution (A) shake a quantity of the powdered tablets equivalent to 0.4 g of Chloroquine sulfate with 50 mL of water R for 30 minutes, centrifuge and use the supernatant liquid; if necessary, filter through a glass-fibre paper and use the clear filtrate. For solution (B) dilute 1 mL of solution A to 100 mL with water R and for solution (C) dilute 5 mL of solution B to 10 mL with water R. For solution (D) dissolve 8 mg of chloroquine sulfate RS in 1 mL of water R. After removing the plate from the chromatographic chamber allow it to dry in air and examine the chromatogram in ultraviolet light (254 nm).

Any spot in the chromatogram obtained with solution A, other than the principal spot, is not more intense than that in the chromatogram obtained with solution B (1.0%) and not more than one such spot is more intense than that in the chromatogram obtained with solution C (0.5%).

Assay

Weigh and powder 20 tablets. Transfer a quantity of the powder equivalent to about 0.5 g of Chloroquine sulfate, accurately weighed, to a separating funnel, add 20 mL of sodium hydroxide (1 mol/L) VS and extract with four quantities, each of 25 mL, of dichloromethane R. Filter each extract through a glass-fibre paper washed with dichloromethane R and kept moistened with the solvent. Dry the combined extracts over 2 g anhydrous sodium sulfate R, filter, wash the residue with 25 mL of dichloromethane R, combine the dichloromethane extracts and evaporate to about 10 mL, add 40 mL of glacial acetic acid R1 and titrate with perchloric acid (0.1 mol/L) VS as described under 2.6 Non-aqueous titration, Method A.

Each mL of perchloric acid (0.1 mol/l) VS is equivalent to 21.8 mg of C18H26ClN3,H2SO4,H2 O.

Dissolution/Disintegration.

  • Either test A or test B may be applied

A. Dissolution. Carry out the test as described under 5.5 Dissolution test for solid oral dosage forms using as the dissolution medium, 500 mL of dissolution buffer, pH 6.8, TS and rotating the paddle at 75 revolutions per minute. At 30 minutes withdraw a sample of 10 mL of the medium through an in-line filter. Measure the absorbance (1.6) of a 1 cm layer of the filtered sample, suitably diluted if necessary, at the maximum at about 342 nm. At the same time measure the absorbance at the maximum at about 342 nm of a suitable solution of chloroquine sulfate RS in dissolution buffer, pH 6.8, TS, using the same buffer as the blank.

For each of the six tablets tested calculate the total amount of chloroquine sulfate (C18H26ClN3,H2SO4) in the medium. The amount in solution for each tablet is not less than 80% of the amount declared on the label. If the amount obtained for one of the six tablets is less than 80%, repeat the test using a further six tablets; the average amount for all 12 tablets tested is not less than 75% and the amount obtained for no tablet is less than 60%.

B. Disintegration. Comply with 5.3 Disintegration test for tablets and capsules operating the apparatus for 10 minutes. If the tablets do not comply carry out test A above.

to previous sectionto next section